In vitro activities of synthetic host defense propeptides processed by neutrophil elastase against cystic fibrosis pathogens.
Version 2 2021-04-12, 15:39
Version 1 2019-11-23, 11:50
journal contribution
posted on 2021-04-12, 15:39 authored by Stephane Desgranges, Florie Le Prieult, Alan Daly, Jennifer LydonJennifer Lydon, Marian BrennanMarian Brennan, Dilip K. Rai, Anusha P. Subasinghage, Chandralal M. Hewage, Sally-Ann CryanSally-Ann Cryan, Catherine GreeneCatherine Greene, Noel G McElvaneyNoel G McElvaney, Timothy P. Smyth, Deirdre Fitzgerald HughesDeirdre Fitzgerald Hughes, Hilary HumphreysHilary Humphreys, Marc DevocelleMarc DevocelleThe antimicrobial and hemolytic activities of a host defense peptide can be controlled by its modification as a propeptide of reduced net charge, which can then be processed by neutrophil elastase, a serine protease involved in chronic airway inflammation and infections associated with cystic fibrosis.
Funding
This publication has emanated from research conducted with the financial support of Science Foundation Ireland (05/RFP/CHE0063 and 06/RFP/CHO024/EC07 to M.D. and 06/RFP/CHO006 to C.M.H.)
History
Comments
The original article is available at http://aac.asm.org/content/55/5/2487.full.pdf+htmlPublished Citation
Desgranges S, Le Prieult F, Daly A, Lydon J, Brennan M, Rai DK, Subasinghage AP, Hewage CM, Cryan SA, Greene C, McElvaney NG, Smyth TP, Fitzgerald-Hughes D, Humphreys H, Devocelle M. In vitro activities of synthetic host defense propeptides processed by neutrophil elastase against cystic fibrosis pathogens. Antimicrobial Agents and Chemotherapy 2011;55(5):2487-9Publication Date
2011-05-01External DOI
PubMed ID
21343449Department/Unit
- Chemistry
- Clinical Microbiology
- Beaumont Hospital
- School of Pharmacy and Biomolecular Sciences
- Medicine
- Undergraduate Research
Usage metrics
Categories
No categories selectedKeywords
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC